Amal M. Johnson Sells 4,635 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Intuitive Surgical Trading Down 0.2 %

Shares of Intuitive Surgical stock opened at $572.71 on Thursday. The firm’s 50 day simple moving average is $548.70 and its two-hundred day simple moving average is $507.04. The firm has a market capitalization of $203.99 billion, a price-to-earnings ratio of 92.08, a PEG ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Hedge Funds Weigh In On Intuitive Surgical

Several hedge funds have recently made changes to their positions in the company. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at about $26,000. Godsey & Gibb Inc. lifted its holdings in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical in the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical in the 4th quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP purchased a new position in Intuitive Surgical during the 3rd quarter worth approximately $38,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages have recently commented on ISRG. Mizuho raised their price target on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. UBS Group lifted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday. Finally, Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.